Enfusion, Inc.
ENFN
$10.76
-$0.04-0.37%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -80.58% | -22.59% | 190.30% | -118.30% | 26.11% |
| Total Depreciation and Amortization | -30.54% | -3.82% | 30.50% | 34.76% | 154.04% |
| Total Amortization of Deferred Charges | 44.93% | 61.39% | 55.89% | 64.16% | 52.05% |
| Total Other Non-Cash Items | 12.98% | -1.41% | 49.26% | 220.36% | -14.92% |
| Change in Net Operating Assets | 111.18% | 266.49% | -200.13% | -39.06% | -243.95% |
| Cash from Operations | 46.87% | 33.50% | 21.54% | 65.91% | -12.43% |
| Capital Expenditure | 26.06% | -15.24% | -25.47% | 57.35% | -154.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -62.57% | -1.33% | -231.52% | -99.15% | 72.38% |
| Cash from Investing | -16.03% | -6.44% | -157.14% | -7.76% | -31.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -99.80% | -- | -- |
| Repurchase of Common Stock | 100.00% | 99.88% | -- | 83.22% | 91.78% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -6.06% | -108.24% | -- |
| Cash from Financing | 100.00% | 99.74% | 99.95% | 78.39% | 91.78% |
| Foreign Exchange rate Adjustments | -445.42% | 255.02% | -118.06% | -481.25% | -10.78% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 56.40% | 256.92% | 105.79% | 65.90% | 495.99% |